Recruiting
Haematological malignancy
RecruitingLong-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel
Registered drugNo placebo
Long-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel
Registered drugNo placebo
- Disease:Haematological malignancy
- Substances:KITE-363Axicabtagene Ciloleucel+1
Countries:
Austria
Austria- Participants:0–17 years · 18–64 years · 65+ years
- Substances:KITE-363
